NADAC acquisition cost data for TERCONAZOLE 0.8% CREAM. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00168034720 | $1.21 | 2022-12-21 | Rx |
| 51672130200 | $1.21 | 2022-12-21 | Rx |
| 00168034720 | $1.21 | 2022-12-21 | Rx |
| 51672130200 | $1.21 | 2022-12-21 | Rx |
Generic: Terconazole | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $4.5M | 128,831 | 88,972 | $2.31 |
| 2020 | $4.4M | 124,829 | 84,346 | $2.33 |
| 2021 | $4.2M | 120,887 | 82,191 | $2.24 |
| 2022 | $4.2M | 119,745 | 81,027 | $2.30 |
| 2023 | $4.1M | 122,626 | 84,152 | $2.07 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $608.4K | 20,094 | 12,829 |
| Florida | $455.5K | 14,051 | 10,125 |
| Texas | $292.6K | 8,860 | 6,400 |
| California | $265.2K | 7,935 | 5,310 |
| Puerto Rico | $256.6K | 7,241 | 5,750 |
| New Jersey | $187.7K | 5,978 | 4,047 |
| Georgia | $160.1K | 4,586 | 3,230 |
| Ohio | $140.8K | 4,227 | 2,893 |
| North Carolina | $135.4K | 3,842 | 2,576 |
| Pennsylvania | $120.1K | 3,335 | 2,249 |
| Illinois | $108.7K | 3,357 | 2,379 |
| Michigan | $102.8K | 2,882 | 1,954 |
| Alabama | $93.8K | 2,770 | 1,917 |
| Virginia | $87.5K | 2,685 | 1,818 |
| Maryland | $83.6K | 2,463 | 1,698 |
| Tennessee | $81.2K | 2,270 | 1,543 |
| Massachusetts | $73.6K | 2,145 | 1,452 |
| Louisiana | $73.0K | 2,284 | 1,599 |
| Connecticut | $65.1K | 1,861 | 1,348 |
| South Carolina | $64.5K | 2,002 | 1,383 |
| Kentucky | $59.7K | 1,959 | 1,380 |
| Indiana | $56.6K | 1,791 | 1,221 |
| Missouri | $48.4K | 1,413 | 1,009 |
| Wisconsin | $40.8K | 1,129 | 715 |
| Arizona | $40.4K | 1,128 | 788 |
| West Virginia | $33.7K | 1,013 | 699 |
| Mississippi | $30.8K | 951 | 666 |
| Arkansas | $28.5K | 794 | 574 |
| Washington | $23.6K | 711 | 470 |
| Oklahoma | $23.1K | 640 | 420 |
| Minnesota | $20.9K | 468 | 325 |
| Colorado | $20.9K | 609 | 400 |
| Nevada | $19.7K | 605 | 390 |
| Kansas | $15.9K | 475 | 330 |
| Iowa | $15.7K | 447 | 315 |
| Maine | $13.9K | 425 | 227 |
| Oregon | $12.9K | 349 | 236 |
| Utah | $12.2K | 303 | 170 |
| New Mexico | $10.6K | 331 | 239 |
| Nebraska | $8.7K | 244 | 186 |
| Hawaii | $8.5K | 223 | 166 |
| Delaware | $8.5K | 277 | 205 |
| Rhode Island | $8.4K | 257 | 190 |
| New Hampshire | $8.0K | 248 | 172 |
| Idaho | $7.6K | 214 | 149 |
| District of Columbia | $7.1K | 209 | 162 |
| North Dakota | $3.4K | 80 | 62 |
| Vermont | $2.9K | 90 | 51 |
| Alaska | $2.5K | 70 | 43 |
| South Dakota | $2.4K | 80 | 56 |
| Montana | $2.3K | 71 | 51 |
| Wyoming | $1.8K | 56 | 37 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.